Bert Van Den Bergh

Bert is a former President of Eli Lilly Neuroscience Products and an executive advisor to Revalesio for all therapeutic programs. He has over 40 years of working experience in the global pharmaceutical industry, mainly in general management, product development, and administration. Bert worked for Eli Lilly and Company for nearly three decades in Belgium, The Netherlands, Indonesia, Venezuela, Germany, the UK, and the USA.